Clinuvel Pharmaceuticals Ltd News

Clinuvel Pharmaceuticals Ltd: Final Director's Interest Notice - Brenda Shanahan

Oct 17 06:20

Clinuvel Pharmaceuticals Ltd: Results of Meeting

Oct 16 10:44

Clinuvel Pharmaceuticals Ltd: Managing Director Presentation

Oct 16 06:14

Clinuvel Pharmaceuticals Ltd: Chair's Address

Oct 16 06:13

Clinuvel Pharmaceuticals Ltd: Appendix 3Y - Karen Agersborg

Oct 3 14:40

Clinuvel Pharmaceuticals Ltd: Notification of cessation of securities - CUV

Oct 2 06:50

Clinuvel Pharmaceuticals Ltd: Canadian New Drug Submission for SCENESSE in EPP filed

Oct 1 06:23

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Sep 27 06:30

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Sep 26 06:28

Clinuvel Pharmaceuticals Ltd: SCENESSE data to be presented at global porphyria conference

Sep 20 06:22

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Sep 19 06:37

Clinuvel Pharmaceuticals Ltd: Notice of Annual General Meeting/Proxy Form

Sep 13 07:24

Clinuvel Pharmaceuticals Ltd: Change of AGM Time of Meeting

Sep 13 07:24

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Pearl Grimes

Sep 10 13:22

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Guy van Dievoet

Sep 10 13:22

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Matthew Pringle

Sep 10 13:21

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Sep 10 06:20

Clinuvel Pharmaceuticals Ltd: Chair's letter to Shareholders

Sep 9 07:26

Clinuvel Pharmaceuticals Ltd: CLINUVEL Board Renewal, Expansion

Sep 6 07:06

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Sep 6 06:22